Arrowstreet Capital
OSIR

Arrowstreet Capital’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Arrowstreet Capital’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-47,112
Closed -$917K – 1630
2015
Q2 		$917K Buy
+47,112
New +$834K 0.01% 843

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arrowstreet Capital's OSIR Position: Q3 2015 in Review

Arrowstreet Capital sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2015, closing a stake of 47,112 shares — an estimated $917K sold.

Arrowstreet Capital first reported a position in OSIR in Q2 2015 and held it in 1 quarter. The position peaked at $917K in Q2 2015. 92 funds tracked by Wall St. Rank hold OSIR as of Q3 2015.

  • Arrowstreet Capital reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Arrowstreet Capital sold 47,112 Osiris Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $917K.
  • Arrowstreet Capital first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Arrowstreet Capital's Osiris Therapeutics, Inc. Common Stock position peaked at $917K in Q2 2015.
  • 92 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Arrowstreet Capital's 13F filing for Q3 2015, filed 5 Nov 2015.